Reconvened Sixty-fifth session of the Commission on Narcotic Drugs, Vienna, Austria, 8-9 December 2022 CCPCJ Chair: Good Morning. (Opening Statement) >>> CND dates 2023 March 13 – 17 CND Chair: Opening Statement (Agenda adopted) Agenda Item 4. Strategic management, budgetary and administrative questions, including the following sub-items: (a) Work of the standing open-ended intergovernmental working …
China
CND thematic sessions on the implementation of all international drug policy commitments, following-up to the 2019 Ministerial Declaration – 21 September 2022
Multiyear Workplan 2019-2023: Implementation of all our international drug policy commitments, following up to the 2019 ministerial declaration “Strengthening Our Actions at the National, Regional and International Levels to Accelerate the Implementation of our Joint Commitments to Address and Counter the World Drug Problem” The provisional agenda for the intersessional meeting is as follows: 1. Thematic …
Committee of the Whole – L7. Intensifying efforts to address the proliferation of uncontrolled and designer precursors used in the illicit manufacture of drugs
L7. Intensifying efforts to address the proliferation of uncontrolled and designer precursors used in the illicit manufacture of drugs USA: We believe its acceptable. I think Iran would like to maintain OP6bis? We include language on human rights, national sovereignty … as my Canadian colleague pointed out. The suggestion of the distinguished delegation from China …
Committee of the Whole L7. Intensifying efforts to address the proliferation of uncontrolled and designer precursors used in the illicit manufacture of drugs
Secretariat: There will be an informal on L5 in a hybrid format on BR-A. L7 – Technical amendment. On OP12 & 13 – There is in square brackets ‘or trafficking’. There was an omission to delete this part. Just checking with the CoW. Ok, we can continue. United States: We engaged in consultations, not in …
Committee of the Whole Resolution L7. Intensifying efforts to address the proliferation of uncontrolled and designer precursors used in the illicit manufacture of drugs (evening session)
Chair: Can the US introduce to us what are the agreements that you could reach during the informal consultations? USA: thank you Sir. I think we’ve had an extensive discussion on the title, and I think we’re pretty close. We have some new flexibility that we want to offer so I might turn it to …
Committee of the Whole. L.7. Intensifying efforts to address the proliferation of uncontrolled and designer precursors used in the illicit manufacture of drugs
Chair: Okay, how far along are we? USA: We recommend starting on the title, we have plenty of suggestions and as this is one of the biggest outstanding issues, I hope we can make substantial progress. USA: (…) EU: We wanted to announce that we intend to co-sponsor this resolution. China: We can not go …